Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

DOI Web Site Web Site 8 Citations

Journal

  • The Lancet

    The Lancet 389 (10068), 519-527, 2017-02

    Elsevier BV

Citations (8)*help

See more

Report a problem

Back to top